• Trim71–Ago2 Control of let-7 in ESC Pluripotency

  2026-09-08

  Liu et al. identify a post-transcriptional mechanism linking the RNA-binding protein Trim71 to Ago2 abundance, mature let-7 microRNAs, and embryonic stem cell fate. Their findings support a conserved Trim71–let-7 bistable switch and show that Ago2 translation, rather than Ago2 degradation, is a critical control point for pluripotency.

• SOX7, DNMT3B, and CYGB in Bladder Cancer

  2026-09-08

  Zhang et al. identify SOX7 as a suppressor of bladder cancer progression and connect its activity to transcriptional repression of DNMT3B, altered CYGB promoter methylation, and reduced malignant behavior. The study combines molecular profiling, clinical tissue analysis, cell-based perturbation, and animal experiments, while also proposing a SOX7–CYGB expression score for prognostic assessment.

• Anlotinib hydrochloride: Assay Reliability Guide

  2026-09-07

  This scenario-driven guide shows how Anlotinib hydrochloride, SKU C8688, can improve interpretation of viability, migration, tube-formation, and signaling assays. It connects nanomolar receptor activity with practical controls, concentration selection, and evidence-based product evaluation.

• KU-55933: ATM Kinase Inhibitor Workflows

  2026-09-07

  Use KU-55933 to interrogate ATM-dependent DNA damage signaling, Akt phosphorylation, cell-cycle control, and cancer-cell phenotypes with a practical, assay-first workflow. This guide also shows how to extend ATM perturbation into cGAS, genome-integrity, and L1 retrotransposition studies without overstating what current evidence proves.

• CCG-1423 for Reliable RhoA Pathway Assays

  2026-09-05

  This scenario-based guide explains how CCG-1423, SKU B4897, can help researchers interpret viability, proliferation, and apoptosis data in RhoA-driven models. It covers mechanism, DMSO formulation, protocol planning, cross-domain viral research, and practical product-selection criteria.

• D-N-Acetylgalactosamine Protocol and QC Guide

  2026-09-04

  D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for glycoprotein composition studies, brain heteropolysaccharides analysis, and related glycosylation pathway workflows. It is suitable for aqueous or validated DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.

• JC-1 Assay Connects Mitochondria to Tumor Angiogenesis

  2026-09-04

  A mechanistic perspective on how mitochondrial membrane potential measurement can strengthen translational studies of LRG1-driven neutrophil dysfunction, NETosis, vascular instability, and treatment resistance in bladder cancer. The article positions the JC-1 Mitochondrial Membrane Potential Assay Kit as a practical ratiometric tool for linking mitochondrial state to apoptosis, mitochondrial function analysis, and therapeutic response while defining the controls and orthogonal assays needed for credible interpretation.

• Apicidin Disrupts Oocyte Quality via Histone Acetylation

  2026-09-03

  A 2026 study shows that Apicidin exposure impairs oocyte meiotic maturation by disrupting spindle assembly, chromosome alignment, actin organization, and histone acetylation. The work connects HDAC-associated epigenetic changes with structural defects, DNA damage, and early apoptosis, providing a focused framework for evaluating the reproductive toxicity of this emerging mycotoxin.

• UK-5099: A Translational Lever for Immunometabolism

  2026-09-03

  UK-5099, also known as PF-1005023, turns mitochondrial pyruvate entry into a controllable variable for mitochondrial metabolism research, immune assays, and glucose-homeostasis studies.

• Pollen Interference in Bioaerosol EEM Analysis

  2026-09-02

  The reference study shows that pollen can distort excitation–emission matrix fluorescence classification of hazardous bioaerosol components because its strong emission resembles biological signatures. Combining spectral preprocessing, fast Fourier transform feature conversion, and random forest classification improved discrimination across 31 sample types and offers a practical strategy for rapid screening.

• Tacrine-Based Hybrids: Evidence and Design Lessons

  2026-09-02

  This review maps tacrine-based hybrid molecules developed between 2006 and 2022, emphasizing multi-target strategies that combine cholinesterase inhibition with activity against amyloid, oxidative, metal-related, inflammatory, or kinase-associated mechanisms. Its main practical contribution is a design framework for retaining the potency of the tacrine scaffold while addressing hepatotoxicity and the multifactorial biology of Alzheimer’s disease.

• FK866 (APO866) for NAD-Driven Cancer Assays

  2026-09-01

  FK866 (APO866) enables mechanism-led studies of NAMPT dependence, NAD depletion, mitochondrial injury, and selective cancer-cell vulnerability. This workflow-focused guide shows how to deploy it in hematologic cancer research and how to adapt the NAD axis to platinum and PARP inhibitor resistance models without overstating cross-tumor evidence.

• D-N-Acetylgalactosamine: Protocol and QC Guide

  2026-09-01

  D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity reagent for aqueous workflows examining glycoprotein constituents, brain heteropolysaccharides, and related glycosylation studies. It is suitable for water or compatible DMSO preparations, but not for ethanol-based protocols or long-term storage of prepared solutions.

• CFTRinh-172: Selective CFTR Inhibitor Guide

  2026-08-31

  CFTRinh-172 is a selective CFTR inhibitor for measuring cAMP-activated chloride transport in epithelial research. Product information reports rapid, reversible, voltage-independent inhibition and a mouse result showing more than 90% suppression of cholera toxin-induced intestinal fluid secretion at 250 μg/kg.

• Nano-Granulated Zoledronate Reprograms Immunity

  2026-08-31

  Chen et al. develop Nano-ZD, a nano-granulated zoledronate formulation that redirects mevalonate-pathway modulation toward lymph node innate immune cells. The study links CoQ depletion to OXPHOS, pyrimidine metabolism, MAVS, and inflammasome signaling, while showing enhanced vaccine and antitumor responses when Nano-ZD is combined with MPLA or αPD-L1.

8196 records 1/547 page Next 12345 下5页 Last page